Acorda Therapeutics, Inc. (ACOR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
04-Dec-19 7:47 AM
View: 
Cohen Ron
President and CEO
Director
Acorda Therapeutics, Inc. (ACOR) 02-Dec-19Sale (Planned) 4,699$1.60$7,505.24(< 1%)
637.14K to 632.44K
04-Dec-19 7:53 AM
View: 
Wasman Jane
President, Intl and GC
Acorda Therapeutics, Inc. (ACOR) 02-Dec-19Sale (Planned) 2,227$1.60$3,552.73(2%)
119.65K to 117.42K
04-Dec-19 7:51 AM
View: 
Sabella Lauren M
Chief Commercial Officer
Acorda Therapeutics, Inc. (ACOR) 02-Dec-19Sale (Planned) 1,513$1.60$2,421.10(11%)
14.14K to 12.62K
04-Dec-19 7:49 AM
View: 
Lawrence David
Chief, Bus. Ops & PAO
Acorda Therapeutics, Inc. (ACOR) 02-Dec-19Sale (Planned) 1,176$1.60$1,879.95(8%)
14.14K to 12.96K
12-Mar-19 4:15 PM
View: 
Hindman Andrew A.
Chief Business Officer
Acorda Therapeutics, Inc. (ACOR) 08-Mar-19Grant 9,045----137%
6.59K to 15.64K
12-Mar-19 4:23 PM
View: 
Sabella Lauren M
Chief Commercial Officer
Acorda Therapeutics, Inc. (ACOR) 08-Mar-19Grant 9,045----178%
5.09K to 14.14K
12-Mar-19 4:21 PM
View: 
Lawrence David
Chief, Bus. Ops & PAO
Acorda Therapeutics, Inc. (ACOR) 08-Mar-19Grant 9,045----178%
5.09K to 14.14K
12-Mar-19 4:13 PM
View: 
Cohen Ron
President and CEO
Director
Acorda Therapeutics, Inc. (ACOR) 08-Mar-19Grant 25,629----4%
611.51K to 637.14K
12-Mar-19 4:25 PM
View: 
Wasman Jane
President, Intl and GC
Acorda Therapeutics, Inc. (ACOR) 08-Mar-19Grant 12,813----12%
106.83K to 119.65K
12-Mar-19 4:11 PM
View: 
Blank Burkhard
CMO and Head of R&D
Acorda Therapeutics, Inc. (ACOR) 08-Mar-19Grant 9,045----28%
32.35K to 41.4K
25-Feb-19 4:19 PM
View: 
Sabella Lauren M
Chief Commercial Officer
Acorda Therapeutics, Inc. (ACOR) 22-Feb-19Market Sale 761$13.18$10,028.20(13%)
5.85K to 5.09K
2%
25-Feb-19 4:17 PM
View: 
Lawrence David
Chief, Bus. Ops & PAO
Acorda Therapeutics, Inc. (ACOR) 22-Feb-19Market Sale 761$13.18$10,028.30(13%)
5.85K to 5.09K
2%
25-Feb-19 4:21 PM
View: 
Wasman Jane
President, Intl and GC
Acorda Therapeutics, Inc. (ACOR) 21-Feb-19Payment of Exercise 953$13.38$12,751.10(< 1%)
107.79K to 106.83K
3%
25-Feb-19 4:15 PM
View: 
Hindman Andrew A.
Chief Business Officer
Acorda Therapeutics, Inc. (ACOR) 21-Feb-19Payment of Exercise 877$13.38$11,734.30(12%)
7.47K to 6.59K
3%
25-Feb-19 4:11 PM
View: 
Cohen Ron
President and CEO
Director
Acorda Therapeutics, Inc. (ACOR) 21-Feb-19Payment of Exercise 2,027$13.38$27,121.30(< 1%)
613.53K to 611.51K
3%
01-Feb-19 4:28 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 30-Jan-19Market Sale 7,000$16.01$112,039.00(< 1%)
4.76M to 4.75M
11%
28-Jan-19 4:09 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 25-Jan-19Market Sale 2,401$16.00$38,416.00(< 1%)
4.76M to 4.76M
11%
28-Jan-19 4:09 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 24-Jan-19Market Sale 8,600$16.03$137,851.00(< 1%)
4.77M to 4.76M
11%
24-Jan-19 4:06 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 23-Jan-19Market Sale 45,898$16.01$734,942.00(< 1%)
4.81M to 4.77M
11%
24-Jan-19 4:06 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 22-Jan-19Market Sale 51,945$16.02$831,972.00(1%)
4.87M to 4.81M
11%
22-Jan-19 4:18 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 18-Jan-19Market Sale 39,358$16.24$639,327.00(< 1%)
4.91M to 4.87M
12%
22-Jan-19 4:18 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 17-Jan-19Market Sale 100,000$16.86$1,685,550.00(2%)
5.01M to 4.91M
15%
17-Jan-19 4:06 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 16-Jan-19Market Sale 91,650$16.94$1,552,410.00(2%)
5.1M to 5.01M
16%
17-Jan-19 4:06 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 15-Jan-19Market Sale 1,700$16.60$28,223.10(< 1%)
5.1M to 5.1M
14%
15-Jan-19 4:32 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 11-Jan-19Market Sale 40,392$17.40$702,788.00(< 1%)
5.14M to 5.1M
18%
11-Jan-19 4:18 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 10-Jan-19Market Sale 87,491$17.29$1,512,730.00(2%)
5.23M to 5.14M
17%
11-Jan-19 4:18 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 09-Jan-19Market Sale 75,000$17.05$1,278,700.00(1%)
5.3M to 5.23M
16%
09-Jan-19 4:22 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 08-Jan-19Market Sale 59,174$16.24$960,927.00(1%)
5.36M to 5.3M
12%
09-Jan-19 4:22 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 07-Jan-19Market Sale 75,000$16.56$1,241,740.00(1%)
5.44M to 5.36M
14%
07-Jan-19 4:08 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 04-Jan-19Market Sale 31,591$16.61$524,714.00(< 1%)
5.47M to 5.44M
14%
07-Jan-19 4:08 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 03-Jan-19Market Sale 23,616$15.74$371,645.00(< 1%)
5.49M to 5.47M
9%
02-Jan-19 4:11 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 28-Dec-18Market Sale 52,891$14.99$792,752.00(< 1%)
5.54M to 5.49M
5%
28-Dec-18 4:11 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 27-Dec-18Market Sale 50,000$14.66$732,760.00(< 1%)
5.59M to 5.54M
2%
28-Dec-18 4:11 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 26-Dec-18Market Sale 50,000$14.66$732,820.00(< 1%)
5.64M to 5.59M
2%
27-Dec-18 8:09 AM
View: 
Cohen Ron
President and CEO
Director
Acorda Therapeutics, Inc. (ACOR) 22-Dec-18Grant 5,980----< 1%
607.55K to 613.53K
27-Dec-18 8:16 AM
View: 
Wasman Jane
President, Intl and GC
Acorda Therapeutics, Inc. (ACOR) 22-Dec-18Grant 2,500----2%
105.29K to 107.79K
27-Dec-18 8:07 AM
View: 
Blank Burkhard
Chief Medical Officer
Acorda Therapeutics, Inc. (ACOR) 22-Dec-18Grant 2,100----7%
30.25K to 32.35K
27-Dec-18 8:11 AM
View: 
Hindman Andrew A.
Chief Business Officer
Acorda Therapeutics, Inc. (ACOR) 22-Dec-18Grant 2,300----44%
5.17K to 7.47K
27-Dec-18 8:14 AM
View: 
Sabella Lauren M
Chief Commercial Officer
Acorda Therapeutics, Inc. (ACOR) 22-Dec-18Grant 2,200----60%
3.65K to 5.85K
27-Dec-18 8:13 AM
View: 
Lawrence David
Chief, Bus. Ops & PAO
Acorda Therapeutics, Inc. (ACOR) 22-Dec-18Grant 2,200----60%
3.65K to 5.85K
26-Dec-18 4:14 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 21-Dec-18Market Sale 40,506$13.23$536,097.00(< 1%)
5.68M to 5.64M
(8%)
21-Dec-18 4:11 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 20-Dec-18Market Sale 40,000$14.03$561,368.00(< 1%)
5.72M to 5.68M
(2%)
21-Dec-18 4:11 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 19-Dec-18Market Sale 5,000$15.93$79,663.90(< 1%)
5.73M to 5.72M
10%
19-Dec-18 4:10 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 18-Dec-18Market Sale 80,000$16.94$1,354,940.00(1%)
5.81M to 5.73M
16%
19-Dec-18 4:10 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 17-Dec-18Market Sale 41,853$16.49$690,102.00(< 1%)
5.85M to 5.81M
13%
17-Dec-18 5:48 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 14-Dec-18Market Sale 28,796$16.15$464,978.00(< 1%)
5.88M to 5.85M
11%
17-Dec-18 5:48 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 13-Dec-18Market Sale 33,061$16.27$537,760.00(< 1%)
5.91M to 5.88M
12%
13-Dec-18 4:09 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 12-Dec-18Market Sale 100,000$16.30$1,629,790.00(2%)
6.01M to 5.91M
12%
13-Dec-18 4:09 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 11-Dec-18Market Sale 200,000$16.30$3,259,500.00(3%)
6.21M to 6.01M
12%
11-Dec-18 4:08 PM
View: 
Scopia Management Inc
10% Owner
Acorda Therapeutics, Inc. (ACOR) 10-Dec-18Market Sale 35,000$19.07$667,530.00(< 1%)
6.25M to 6.21M
25%